Sicagen India Consolidated December 2020 Net Sales at Rs 159.49 crore, down 17.3% Y-o-Y
NULL10-02-2021
SICAGEN INDIA LTD. - 533014 - Outcome Of The Board Meeting
Sicagen India Limited has informed the Exchange regarding Board meeting held on February 10, 2021.10-02-2021
SICAGEN INDIA LTD. - 533014 - Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2020
Sicagen India Limited submitted to the Exchange, the Unaudited Financial results for the quarter and nine months ended 31st December 202010-02-2021
SICAGEN INDIA LTD. - 533014 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Sicagen India Limited has informed the Exchange about Loss of Share Certificates02-02-2021
SICAGEN INDIA LTD. - 533014 - Board Meeting Intimation for The Consideration Of Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended 31St December 2020.
SICAGEN INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2021 ,inter alia, to consider and approve the Unaudited financial results of the Company for the quarter and nine months ended 31st December 2020.29-01-2021
SICAGEN INDIA LTD. - 533014 - Announcement under Regulation 30 (LODR)-Strikes /Lockouts / Disturbances
Sicagen India Limited has informed the Exchange regarding a Fire accident in Industrial Packaging Division (IPD) plant of the Company23-01-2021
SICAGEN INDIA LTD. - 533014 - Shareholding for the Period Ended December 31, 2020
Sicagen India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here20-01-2021
SICAGEN INDIA LTD. - 533014 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- R SrikrishnaDesignation :- Company Secretary and Compliance Officer05-01-2021
SICAGEN INDIA LTD. - 533014 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Sicagen India Limited has submitted to the Exchange, the Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st December, 202005-01-2021
SICAGEN INDIA LTD. - 533014 - Closure of Trading Window
This is to inform that, the Trading Window for dealing in equity shares of the Company by the Designated persons and their immediate relatives will remain closed from January 01, 2021 till 48 hours after the declaration of Un audited Financial Results for the quarter and nine months ended December 31, 2020, as per the Company's Code of Conduct to regulate, monitor and report trading by insiders adopted by the Board pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.31-12-2020